Guggenheim Raises its Price Target on Bristol-Myers Squibb Company (BMY) to $72 and Reiterates a Buy Rating
Business
Archived
•
February 9, 2026
•
Source: https://finance.yahoo.com/rss/topstories - Read Original
"5000+ Emails weekly."
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!
Sponsored
"House Plans for Structures New and Old"
"What you put in is not always what you get out."